Physician profile
James Henry Fitzpatrick
NPI 1104970466
$1,807.76
in general payments reported to CMS, 2019-2025
28 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $341 · 2023: $805 · 2024: $232 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,246.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $355.75 | 2022-2024 | Jelmyto |
| Janssen Biotech, INC. | $233.11 | 2021-2025 | Carvykti, Rybrevant, Erleada |
| Abbvie INC. | $214.61 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $130.44 | 2023-2024 | Prolaris |
| Endo Pharmaceuticals INC. | $87.73 | 2021-2023 | Aveed, Xiaflex |
| 180 Medical, INC. | $87.15 | 2022-2024 | |
| Boston Scientific Corporation | $77.34 | 2021-2024 | Rezum Generator |
| Sumitomo Pharma America, INC. | $64.45 | 2023 | Orgovyx, Gemtesa |
| Urovant Sciences INC | $53.26 | 2022 | |
| Merck Sharp & Dohme LLC | $50.44 | 2021-2022 | |
| Astellas Pharma US INC | $43.66 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $38.05 | 2024 | Adstiladrin |
| Tolmar, INC. | $37.64 | 2023 | |
| Axonics, INC. | $36.36 | 2023-2024 | Axonics, Bulkamid |
| Angiodynamics, INC. | $32.35 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $31.98 | 2023-2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $29.09 | 2021 | |
| Dentsply Ih Ab | $27.50 | 2023 | Lofric |
| Procept Biorobotics Corporation | $27.06 | 2023 | Aquabeam Robotic System |
| Blue Earth Diagnostics | $20.79 | 2021 | |
| Hollister Incorporated | $18.38 | 2021 | |
| Antares Pharma, INC. | $17.19 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.46 | 2023 | Givlaari |
| Halozyme INC | $16.33 | 2023 | |
| Abc Home Medical Supply, INC. | $15.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2023 | Lynparza |
| Allergan, INC. | $15.26 | 2021 | |
| Monaghan Medical Corporation | $13.49 | 2023 | Aerochamber |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fitzpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.